ストックスクリーナーアプリを入手
43.45
2.05%
-0.91
アフターアワーズ：
43.90
0.45
+1.04%
Vera Therapeutics Inc (VERA) 最新ニュース
Fordyce, Vera Therapeutics CEO, sells $1m in VERA stock - Investing.com
[Form 4] Vera Therapeutics, Inc. Insider Trading Activity - Stock Titan
Polycythemia Vera Market: Rapid Increment Driven by Innovation - openPR.com
Vertex Sues Former Exec To Block Move To Rival - Law360
VERA (NASDAQ: VERA) director sells 16,925 shares for $710,577.51 — Form 144 - Stock Titan
Panic Selling: Is Vera Therapeutics Inc vulnerable to short sellersQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Discipline and Rules-Based Execution in VERA Response - Stock Traders Daily
Vera Therapeutics Announces Inducement Grants - National Today
Vera Therapeutics (VERA) Valuation Check After Recent Share Price Rebound - Sahm
Risk Check: Does Vera Therapeutics Inc align with a passive investing strategyTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Vera Therapeutics stock rises after crossing above key SMA - Intellectia AI
Published on: 2026-04-11 13:37:36 - baoquankhu1.vn
Can Vera Therapeutics Inc deliver consistent EPS growth2026 Bull vs Bear & High Yield Stock Recommendations - baoquankhu1.vn
Vera Therapeutics Grants Inducement Awards to New Employees Under 2024 Inducement Plan - Quiver Quantitative
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Vera Therapeutics issues stock awards to 89 new employees - Stock Titan
Is Vera Therapeutics (VERA) Still Attractive After An 87% One Year Share Price Surge - Yahoo Finance
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Board of Vera Therapeutics (VERA) seeks votes on directors, auditor and say-on-pay - Stock Titan
Is It Too Late To Consider Vera Therapeutics (VERA) After Its Recent Share Price Surge? - Sahm
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight - GlobeNewswire Inc.
BofA Initiates Coverage of Vera Therapeutics (VERA) With a Buy Rating - MSN
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vera Therapeutics Adds Experienced Legal Chief As Shares Trade Below Targets - Sahm
Behavioral Patterns of VERA and Institutional Flows - Stock Traders Daily
Point72 (NASDAQ: VERA) reports 1.7% holding, 1.23M shares disclosed - Stock Titan
Big Picture: What is the next catalyst for Vera Therapeutics Inc2026 Support & Resistance & Technical Pattern Based Signals - baoquankhu1.vn
Day Trade: How cyclical is Vera Therapeutics Incs revenue stream2026 News Drivers & Technical Pattern Based Buy Signals - baoquankhu1.vn
Is Vera Therapeutics (VERA) Pricing Reflect Its DCF Upside After Recent Share Price Weakness - Sahm
VERA SEC FilingsVera Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
New Vera legal chief gets 56,850 options and 42,403 RSUs - Stock Titan
Vanguard disaggregates holdings; Vera Therapeutics (VERA) shows 0 shares reported - Stock Titan
Equity grants to Vera Therapeutics (VERA) Chief Legal Officer detailed in Form 4 - Stock Titan
Chief Legal Officer reports initial insider status at Vera Therapeutics (VERA) - stocktitan.net
Calif. Biotech Firm Vera Taps Vaxcyte Ex-GC As New CLO - Law360
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer By Investing.com - Investing.com Canada
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer - Investing.com
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer - The Manila Times
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock advances on promising Phase 3 data for atacicept in IgA nephropathy, boostin - AD HOC NEWS
Why Vera Therapeutics Shares Are Sinking Today - TipRanks
(VERA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Investment Firm Boosts Vera Therapeutics Holding to $41.75M in 2026News and Statistics - IndexBox
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year - The Motley Fool
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year - Bitget
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics - National Today
Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Is Suddenly Taking Off - TipRanks
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Deep Track Capital, LP Increases Stake in Vera Therapeutics Inc - GuruFocus
Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) finance chief exercises options for 10,000 shares - Stock Titan
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment - AOL.com
Eversept Partners Increases Stake in Vera Therapeutics - Intellectia AI
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):